VDAC1 and neurodegenerative disease: There is broad evidence showing the participation of VDAC-1 in Parkinson’s disease via its interaction with α-synuclein mediating its transport via the pore-regulating Ca2+-homeostasis [35], altogether providing evidence for the involvement of VDAC-1 in neurodegenerative diseases [34,36].